Steve Salop

@stevesalop.bsky.social

Prof of Econ & Law Emeritus, Georgetown Law Antitrust & Competition, IO Econ, Law and Psych Post-Chicago & Still Evolving https://papers.ssrn.com/sol3/cf_dev/AbsByAuth.cfm?per_id=68535 https://www.law.georgetown.edu/faculty/steven-c-salop/

This is the most relevant article to NIH and research cuts I’ve seen. Imagine if this was today , how many people would be saying “Why are we studying Gila Monsters and their impact on diabetes ? That’s wasted money !” globalnews.ca/news/9793403...

How a Canadian scientist and a venomous lizard helped pave the way for Ozempic - National | Globalnews.ca

In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.

globalnews.ca

It sounded like the FTC trial team did not think they had enough time. And on the webinar today, it sounded like they did not have the resources for experts. But given that, they probably should’ve dropped the count. like the way the DOJ should’ve dropped AT&T/TW when they drew Judge Leon.

Post nicht verfügbar.

If every older Democrat successfully explains to a younger person that retaining democracy by electing Biden is essential, then it will be. Trump is more entertaining but detention camps and revitalized Russia power will not be.

I'm amused at antitrust lawyers trying to treat the 5th Cir decision in Illumina/Grail as an FTC loss. The Court affirmed the FTC on anticompetitive effects -- a big Win. On the sufficiency of the Illumina's voluntary fix, the Court adopted Comm Wilsons approach, but she rejected that remedy.

Ethical Rules for Economists-1 (Please expand) . 1. Avoid Pareto Inferior outcomes. 2. Don't create or threaten negative externalities. 3. Minimize unavoidable negative externalities; compensate where appropriate. 4. Don't exploit decision-making flaws of lower income - vulnerable consumers